Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11707472 Compositions for the treatment of fibrosis

Patent 11707472 was granted and assigned to Viking Therapeutics on July, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Viking Therapeutics
Viking Therapeutics
0
Date Filed
June 4, 2018
0
Date of Patent
July 25, 2023
0
Patent Applicant
Viking Therapeutics
Viking Therapeutics
0
Patent Application Number
16617471
0
Patent Citations
‌
US Patent 10925885 Thyromimetics for the treatment of fatty liver diseases
0
‌
US Patent 11202789 Method of treating glycogen storage disease
0
‌
US Patent 7402602 Imidazole derivatives modulating the sodium channels
0
‌
US Patent 7514419 Phosphorus-containing thyromimetics
0
‌
US Patent 7799782 P38 inhibitors and methods of use thereof
0
‌
US Patent 7829552 Phosphorus-containing thyromimetics
0
‌
US Patent 10130643 Thyromimetics for the treatment of fatty liver diseases
0
Patent Citations Received
‌
US Patent 12102646 Compositions for the treatment of fibrosis and inflammation
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11707472
0
Patent Primary Examiner
‌
Samira J Jean-Louis
0
CPC Code
‌
A61K 9/0019
0
‌
A61K 31/664
0
‌
A61K 31/675
0
‌
A61K 45/06
0
‌
A61K 31/662
0
‌
A61K 31/663
0
‌
A61P 19/04
0
‌
A61P 1/16
0
‌
A61K 31/683
0
‌
A61K 31/19
0
•••

Find more entities like US Patent 11707472 Compositions for the treatment of fibrosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.